PDF(Pubmed)
Abstract：
We set out to map evidence of disparities in Alzheimer\'s disease and Alzheimer\'s disease related dementias healthcare, including issues of access, quality, and outcomes for racial/ethnic minoritized persons living with dementia (PLWD) and family caregivers.
We conducted a scoping review of the literature published from 2000 to 2022 in PubMed, PsycINFO, and CINAHL. The inclusion criteria were: (1) focused on PLWD and/or family caregivers, (2) examined disparities or differences in healthcare, (3) were conducted in the United States, (4) compared two or more racial/ethnic groups, and (5) reported quantitative or qualitative findings.
Key findings include accumulating evidence that minoritized populations are less likely to receive an accurate and timely diagnosis, be prescribed anti-dementia medications, and use hospice care, and more likely to have a higher risk of hospitalization and receive more aggressive life-sustaining treatment at the end-of-life.
Future studies need to examine underlying processes and develop interventions to reduce disparities while also being more broadly inclusive of diverse populations.
We conducted a scoping review of the literature published from 2000 to 2022 in PubMed, PsycINFO, and CINAHL. The inclusion criteria were: (1) focused on PLWD and/or family caregivers, (2) examined disparities or differences in healthcare, (3) were conducted in the United States, (4) compared two or more racial/ethnic groups, and (5) reported quantitative or qualitative findings.
Key findings include accumulating evidence that minoritized populations are less likely to receive an accurate and timely diagnosis, be prescribed anti-dementia medications, and use hospice care, and more likely to have a higher risk of hospitalization and receive more aggressive life-sustaining treatment at the end-of-life.
Future studies need to examine underlying processes and develop interventions to reduce disparities while also being more broadly inclusive of diverse populations.
摘要：
背景：我们着手绘制阿尔茨海默病和阿尔茨海默病相关痴呆症医疗保健差异的证据，包括访问问题，质量,以及种族/族裔少数族裔痴呆症患者（PLWD）和家庭护理人员的结果。
方法：我们对2000年至2022年在PubMed上发表的文献进行了范围审查，PsycINFO,和CINAHL。纳入标准为：（1）侧重于PLWD和/或家庭护理人员，(2)检查医疗保健方面的差异或差异，（3）在美国进行，（4）比较两个或两个以上的种族/民族，(5)报告定量或定性结果。
结果：主要发现包括积累的证据表明，少数人群不太可能获得准确及时的诊断，被处方抗痴呆药物，并使用临终关怀护理，并且更有可能有更高的住院风险，并在生命结束时接受更积极的维持生命的治疗。
结论：未来的研究需要检查潜在的过程，并制定干预措施，以减少差异，同时更广泛地包括不同的人群。
方法：我们对2000年至2022年在PubMed上发表的文献进行了范围审查，PsycINFO,和CINAHL。纳入标准为：（1）侧重于PLWD和/或家庭护理人员，(2)检查医疗保健方面的差异或差异，（3）在美国进行，（4）比较两个或两个以上的种族/民族，(5)报告定量或定性结果。
结果：主要发现包括积累的证据表明，少数人群不太可能获得准确及时的诊断，被处方抗痴呆药物，并使用临终关怀护理，并且更有可能有更高的住院风险，并在生命结束时接受更积极的维持生命的治疗。
结论：未来的研究需要检查潜在的过程，并制定干预措施，以减少差异，同时更广泛地包括不同的人群。
